Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Govoni

Showing results (41-50 of 254) with videos related to

Pageof 26
Sort By:
Autoimmunity Reviews|August 10, 2010
The role of adenosine receptors in rheumatoid arthritisKatia Varani, Melissa Padovan, Marcello Govoni, et al.
BMJ Open|September 13, 2018
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databasesEttore Silvagni, Alessandra Bortoluzzi, Greta Carrara, et al.
Reumatismo|January 30, 2025
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?Beatrice Maranini, Roberta Foti, Moustapha Taha, et al.
Frontiers in Medicine|October 13, 2022
Ultrasound response to tofacitinib in patients with rheumatoid arthritis: Data from a multicenter 24 weeks prospective studyGiuseppe Germanò, Pierluigi Macchioni, Beatrice Maranini, et al.
Clinical Rheumatology|December 18, 2025
Ultrasound assessment of temporomandibular disorders: comparative analysis between inflammatory and degenerative patterns in rheumatic and non-rheumatic patientsBeatrice Maranini, Stefano Mandrioli, Giovanni Ciancio, et al.
Expert Review of Clinical Pharmacology|September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Life (Basel, Switzerland)|February 25, 2022
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative ReviewBeatrice Maranini, Giovanni Ciancio, Manuela Ferracin, et al.
Frontiers in Immunology|August 28, 2023
Case Report: Middle lobe syndrome: a rare presentation in eosinophilic granulomatosis with polyangiitisBeatrice Maranini, Ippolito Guzzinati, Gian Luca Casoni, et al.
Clinical and Experimental Rheumatology|June 25, 2014
Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendationsRoberto Caporali, Fabrizio Conti, Michele Covelli, et al.
Biologics : Targets & Therapy|December 10, 2025
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature ReviewGiorgio Galoppini, Carlo Garaffoni, Andrea Lotesoriere, et al.
Pageof 26

Showing results (41-50 of 254) with videos related to

Sort By:
Pageof 26
Autoimmunity Reviews|August 10, 2010
The role of adenosine receptors in rheumatoid arthritisKatia Varani, Melissa Padovan, Marcello Govoni, et al.
BMJ Open|September 13, 2018
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databasesEttore Silvagni, Alessandra Bortoluzzi, Greta Carrara, et al.
Reumatismo|January 30, 2025
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?Beatrice Maranini, Roberta Foti, Moustapha Taha, et al.
Frontiers in Medicine|October 13, 2022
Ultrasound response to tofacitinib in patients with rheumatoid arthritis: Data from a multicenter 24 weeks prospective studyGiuseppe Germanò, Pierluigi Macchioni, Beatrice Maranini, et al.
Clinical Rheumatology|December 18, 2025
Ultrasound assessment of temporomandibular disorders: comparative analysis between inflammatory and degenerative patterns in rheumatic and non-rheumatic patientsBeatrice Maranini, Stefano Mandrioli, Giovanni Ciancio, et al.
Expert Review of Clinical Pharmacology|September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Life (Basel, Switzerland)|February 25, 2022
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative ReviewBeatrice Maranini, Giovanni Ciancio, Manuela Ferracin, et al.
Frontiers in Immunology|August 28, 2023
Case Report: Middle lobe syndrome: a rare presentation in eosinophilic granulomatosis with polyangiitisBeatrice Maranini, Ippolito Guzzinati, Gian Luca Casoni, et al.
Clinical and Experimental Rheumatology|June 25, 2014
Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendationsRoberto Caporali, Fabrizio Conti, Michele Covelli, et al.
Biologics : Targets & Therapy|December 10, 2025
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature ReviewGiorgio Galoppini, Carlo Garaffoni, Andrea Lotesoriere, et al.
Pageof 26